Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many commercial agreements NHS England has agreed with manufacturers of medicines that allow, support or result in non-uniform pricing by medicine.
Since 2020 NHS England has agreed 24 commercial agreements that have resulted in non-uniform pricing by medicine, via either the Cancer Drugs Fund or through bespoke commercial deals to support routine commissioning.